Relating to information reported to the Department of Consumer and Business Services.
Summary
Allows Department of Consumer and Business Services to access data in All Payer All Claims database by certifying data will only be used to carry out department's duties. Protects from disclosure personally identifiable information about consumers who report to department price increases for prescriptions drugs. Requires pharmaceutical manufacturers to report to department information about patient assistance programs offered to consumers for certain new prescription drugs introduced for sale in United States. Requires all insurers offering health benefit plans to annually report to department data about prescription drugs covered by plans.
Bill status
failed
3 of 5 stages cleared
Introduction
Jan 2021
Committee Review
Mar 2021
House Passage
Apr 2021
Senate Passage
Governor
Introduced Jan 11, 2021
Last action Apr 10, 2021
Floor votes · House Apr 9, 2021
How they voted
21–16
Passed · 8 other
Total votes 45
Apr 9, 2021
D
Democratic29
72% Yea
R
Republican16
68% Nay
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
18
Key actions
2
Committee
2
Apr 9, 2021
House · Passed
House Vote: pass (21-16-8)
house
Mar 27, 2021
Lower · Passed
Recommendation: Do pass.
lower
Jan 20, 2021
Committee
Referred to Health Care.
lower
Jan 11, 2021
Introduced
First reading. Referred to Speaker's desk.
lower
0 primary · 0 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 2044
Scope: OR
Hi! I can help you understand HB 2044. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline